Oncoheroes Biosciences is proud to announce we have been selected as one of the eleven finalists of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit. Scheduled for May 14th–15th, 2024, at the Cleveland Clinic Abu Dhabi, this event aims to cultivate a thriving ecosystem for early-stage entrepreneurs in the life sciences sector.
The summit, sponsored by J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors, and United AlSaqer Group, coincides with the Abu Dhabi Global Healthcare Week, drawing top-tier innovators and investors from around the globe. With a focus on fostering scientific innovation in Abu Dhabi, the summit seeks to propel the growth of the region's life sciences industry.
Cesare Spadoni, Oncoheroes Biosciences’ co-founder and COO, will present Oncoheroes’ pioneering work to a panel of judges comprising industry leaders and investors, including Dr. Laurie Glimcher, President and CEO of the Dana-Farber Cancer Institute, Dr. Jorge Guzman, CEO of the Cleveland Clinic Abu Dhabi, Prof. Shahrukh Khurshid Hashmi, Director of Research at the Department of Health of Abu Dhabi, Dr. David Hung, President and CEO at Nuvation Bio, Dr. Yasmine Hayek Kobeissi, Executive Director at Blue Horizon Advisors, and Ms. Anya Schiess, Managing Partner at J.P. Morgan Life Sciences Private Capital. This recognition highlights Oncoheroes Biosciences' commitment to advancing novel treatments for childhood cancers.